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Obstructive diseases of blood vessels and the lung are
characterized by degradation and synthesis of new
extracellular matrix (ECM) components. Regulated re-
modeling of the ECM in diseases such as atheroscle-
rosis and lymphangioleiomyomatosis (LAM), both
characterized by excessive accumulation of smooth
muscle cells (SMCs), is thought to be controlled in
part by cell surface receptors for specific ECM com-
ponents. Discoidin domain receptors (DDR) 1 and 2
represent a family of tyrosine kinase collagen recep-
tors that are activated by fibrillar collagens. To test the
hypothesis that DDR may be involved in ECM remod-
eling by SMCs in vivo , we analyzed DDR expression
by reverse transcriptase-polymerase chain reaction
and immunohistochemistry and demonstrate that
both DDR1 and DDR2 are up-regulated in nodules of
LAM as compared to normal controls, and are ex-
pressed in lesions of atherosclerosis. In vitro , retro-
viral overexpression of DDR1 or DDR2 in human
SMCs cultured on polymerized collagen gels leads to a
reduction of collagen expression and induces matrix
metalloproteinase (MMP) 1 at both mRNA and protein
levels, but only DDR2 enhances MMP2 activation.
Moreover, DDR2 overexpression increases SMC-me-
diated collagen and elastin degradation in vitro. Using
laser microdissection, we extend our studies to the
analysis of SMCs from LAM nodules where we observe
higher MMP1 expression and MMP2 activation. Taken
together, these data provide evidence for the poten-
tial roles of DDR1 and DDR2 in the regulation of
collagen turnover mediated by SMCs in obstructive
diseases of blood vessels and the lung. (Am J Pathol
2004, 164:1575–1585)
The extracellular matrix (ECM) is a dynamic structure that
not only provides a scaffold for mechanical support and
organization of tissues, but also regulates critical events
in normal development and pathological conditions.
Therefore, synthesis and degradation of the ECM must
be tightly regulated, and the net balance between neo-
synthesis and breakdown will determine the final compo-
sition of ECM components in tissues.1 Although the ac-
tion of several growth factors and cytokines can directly
regulate collagen biosynthesis,2 and three classes of
enzymes—matrix metalloproteinase (MMPs), serine pro-
teases, and cysteine proteases—have been implicated
in ECM breakdown,1,3,4 the molecular mechanisms reg-
ulating the remodeling of major ECM components, such
as collagen and elastin, are still poorly understood.
During the formation of the lesions of atherosclerosis,
deposition of new ECM components, in particular colla-
gens type I and III, and increased expression of MMP are
observed.5–10 Dynamic changes in ECM composition
within the vessel wall have been proposed to play an
important role in excessive smooth muscle cell (SMC)
accumulation, a key event in atherosclerosis.3,5,8,11
Moreover, a critical factor in the clinical sequelae asso-
ciated with lesions of atherosclerosis, such as myocardial
infarction, is the integrity of interstitial type I collagen
present in the fibrous cap that covers the atherosclerotic
lesions—the higher the content of SMCs and intact type I
collagen, the less prone the fibrous cap is to rupture.5,12
Excessive accumulation of SMCs around bronchioles,
pulmonary arteries, and venules, in association with
Supported by the National Institutes of Health (grant no. HL18645 to
E.W.R.), a LAM Foundation Award (to N.F.), and National Center for
Research Resources grant RR-00166 to the Northwest Primate Center.
Accepted for publication January 12, 2004.
Current address of N.F.: Department of Pharmacologic Sciences, Uni-
versity of Milan, Milan 20133 Italy.
Current address of N.O.C.: Beatson Institute for Cancer Research,
Cancer Research UK, Glasgow G61 1BD, Scotland UK.
Address reprint requests to Elaine W. Raines, Department of Pathology,
Harborview Medical Center, 325 9th Ave., Box 359675, Seattle, WA
98104-2499. E-mail: ewraines@u.washington.edu.
American Journal of Pathology, Vol. 164, No. 5, May 2004
Copyright © American Society for Investigative Pathology
1575
MMP-dependent degradation of fibrillar collagen and
elastic fibers is also observed during lymphangio-
leiomyomatosis (LAM).13–16 LAM is a rare disorder that
occurs either sporadically or in association with tuberous
sclerosis affecting primarily women of reproductive
age.13,15 SMC accumulation and degeneration of colla-
gen and elastin fibers leads to respiratory failure in LAM
patients, who normally die within 5 to 10 years after the
onset of symptoms.13,15
Regulated remodeling of the ECM in disease pro-
cesses such as atherosclerosis and LAM is poorly under-
stood but is thought to be regulated in part by cell surface
receptors for specific ECM. Until recently, cell-ECM inter-
actions have been ascribed primarily to integrins.17,18
The identification of discoidin domain receptors 1 and 2
(DDR1 and DDR2) as collagen receptors with tyrosine
kinase activity constitutes an alternative mechanism for
mediating cell-matrix adhesion and transmitting ECM sig-
nals to cells.19,20 Evidence from the generation of DDR1-
and DDR2-null mice, and in vitro studies, suggest that
DDR can regulate cell proliferation and ECM remodeling
mediated by MMP activities during normal development
and/or pathological conditions.21–26
In the present study, we investigate the role of DDRs in
SMC-mediated collagen remodeling, and characterize
their expression at different stages of atherosclerotic le-
sion development and in LAM disease. Our data demon-
strate that signaling from DDR1 and DDR2 down-regu-
lates collagen type I production and induces collagen
degradation through the induction of collagenase I
(MMP1) and activation of gelatinase A (MMP2). Using
laser microdissection technology, we extend our obser-
vations in cultured human SMCs to LAM nodules where
we observe higher expression of MMP1 and activation of
MMP2 as compared to normal lung. Thus, our study
provides evidence that collagen-mediated activation of
both DDR1 and DDR2 in SMCs may contribute to the
turnover and remodeling of collagen in lesions of athero-
sclerosis and LAM.
Materials and Methods
Cell Culture and Collagen Matrix Preparation
Human newborn arterial SMCs were isolated from the
thoracic aorta as previously described.27 SMCs between
passages 5 and 9 were cultured in 1% plasma-derived
serum/Dulbecco’s modified Eagle’s medium (DMEM) on
the surface of the following collagen type I preparations:
three-dimensional polymerized collagen gels (1.0 mg/ml
final concentration) prepared by neutralization of the col-
lagen solution (Vitrogen 100; Cohesion Technologies,
Palo Alto, CA) with 1/6 vol of 7 concentrated DMEM,
dilution to a final 1 DMEM solution, and incubation at
37°C for 24 hours.28 Monomer collagen-coated dishes
were prepared by incubating 0.1 mg/ml of collagen so-
lution in 0.1 mol/L of acetic acid at 37°C for 24 hours and
washing twice with DMEM before cell seeding.
Reagents and Antibodies
The broad-based metalloproteinase inhibitor GM6001
was purchased from Elastin Products Co., and Coomas-
sie Blue R250 from Sigma Chemical Co. (St. Louis, MO).
The following antibodies were used for immunostaining:
rabbit polyclonal anti-DDR1 (C20, 3 g/ml; Santa Cruz
Biotechnology, Santa Cruz, CA), goat polyclonal anti-
DDR2 (N20, 9 g/ml; Santa Cruz Biotechnology), normal
rabbit IgG (Vector Laboratories, Burlingame, CA), normal
goat IgG (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA), anti--actin (1 g/ml; DAKO, Carpinte-
ria, CA), and anti-HAM-56.29 For competition experi-
ments, DDR1-blocking peptide (SC-532 P, Santa Cruz
Biotechnology) and DDR2-blocking peptide (sc-7555 P,
Santa Cruz Biotechnology) were used. For Western blot
analysis, the following antibodies were used: rabbit poly-
clonal anti-HA (Zymed Laboratories, South San Fran-
cisco, CA); mouse monoclonal to phosphotyrosine resi-
dues (clone 4G10; Upstate Technology, Lake Placid,
NY); mouse monoclonal anti-MMP1 (Calbiochem, La
Jolla, CA); rabbit polyclonal anti-DDR1 (C20, Santa Cruz
Biotechnology); goat polyclonal anti-DDR2 (H-108, Santa
Cruz Biotechnology). Protein G-Plus agarose was pur-
chased from Santa Cruz Biotechnology.
Protein Analysis and Immunoprecipitation
Cells were washed twice with phosphate-buffered saline
(PBS) and lysed (50 mmol/L Tris, pH 7.5, 150 mmol/L
NaCl, 0.5% Nonidet P-40, 1 mmol/L phenylmethyl sulfonyl
fluoride, 1 mmol/L NaVO4, 1 g/ml aprotinin, 1g/ml leu-
peptin, and 1 g/ml pepstatin) for 30 minutes on ice. Cell
lysates were cleared by centrifugation at 15,000  g for
20 minutes, and protein concentrations were determined
using the BCA protein assay (Pierce, Rockford, IL). For
protein analysis of control and LAM tissues, five 20-m-
thick frozen sections were placed into a microfuge tube,
washed twice with PBS, and lysed as described above.
Lysates were separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis under reducing condi-
tions, transferred to Immobilon polyvinylidene difluoride
(Millipore, Bedford, MA), and subsequently immunoblot-
ted with specific antibodies, before visualization by en-
hanced chemiluminescence (Amersham Corp., Arlington
Heights, IL). For immunoprecipitations, 200 g of protein
extracts from human SMCs were incubated with 5 g of
anti-HA antibody at 4°C. After 2 hours, protein G-Plus
Agarose was added and the incubation was continued
overnight. Samples were washed three times with lysis
buffer and eluted with 1 sodium dodecyl sulfate elec-
trophoresis-loading buffer.
Gelatin Zymography
Cell lysates were prepared as described above, and
conditioned media were collected from SMC cultures.
Samples were prepared in nonreducing loading buffer
and separated on 10% sodium dodecyl sulfate-polyac-
rylamide gel containing 1 mg/ml of gelatin. After electro-
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phoresis, gels were washed three times in washing solu-
tion (150 mmol/L NaCl and 2.5% Triton X-100) for 30
minutes, rinsed in water, and incubated for 12 to 16 hours
in collagenase buffer (50 mmol/L Tris-HCl, pH 7.5, 150
mmol/L NaCl, and 10 mmol/L CaCl2). Gels were subse-
quently fixed and stained in Coomassie Blue fixative so-
lution (25% methanol, 7% acetic acid, and 0.25% Coo-
massie Blue R250) for 2 hours at room temperature and
destained with washing solution (25% methanol and 7%
acetic acid in water) for 4 to 5 hours.
RNA Preparation and Northern Blot
Total RNA was prepared from SMCs cultured on poly-
merized collagen gels with StrataPrep Total RNA Mini-
prep kit (Stratagene, La Jolla, CA) according to the manu-
facturer’s instructions. Ten g of total RNA were subjected
to a Northern blot procedure using a modification of the
methods pioneered by Alwine and colleagues.30 Briefly,
total RNA samples were separated on 1.5% agarose gels
containing formaldehyde, transferred by capillary action to
a nylon membrane (Hybond, Amersham Pharmacia Bio-
tech), and UV cross-linked to the membrane. Probes were
radiolabeled with -32P dCTP by using the Rediprime II kit
(Amersham Pharmacia Biotech) according to manufactur-
er’s instructions. Radiolabeled probes were added to ex-
press-hyb solution (Clontech, Palo Alto, CA) and allowed to
hybridize for 1 hour at 68°C after a prehybridization for 30
minutes at 68°C. After hybridization, membranes were
washed and the gel exposed to Kodak BioMax film (East-
man-Kodak, Rochester, NY).
Probes for specific hybridization to DDR1 a, b, and c
isoforms (1543 to 1873 bp), DDR1 b and c isoforms (1657
to 1770 bp), DDR2 (1708 to 2093 bp), MMP1 (284 to 845
bp), MMP2 (361 to 899 bp), Col1(I) (1212 to 1690 bp),
and GAPDH (360 to 695 bp) were generated by polymer-
ase chain reaction (PCR) amplification of cDNA derived
from human SMCs.
Reverse Transcriptase (RT)-PCR
For RT-PCR total RNA was extracted from 50 to 100 mg of
frozen tissues using the StrataPrep Total RNA Miniprep
kit (Stratagene) according to the manufacturer’s instruc-
tions. First-strand cDNA synthesis was performed with 1
g of total RNA and oligo-dT primer, using SuperScript
Preamplification System for First Strand cDNA Synthesis
(Invitrogen, Carlsbad, CA). PCR reactions were per-
formed using specific human DDR1 isoform primers pre-
viously described (5-ATCCTGCTCCTGCTGCTCATCA-
3, 5-ATCTTGAGGGCTGTCGACC TCA-3),31 DDR2
primers spanning the juxtamembrane and transmem-
brane domains (5-ATCCTGATTGGCTGCTTGGTGGCC-
3, 5-CTCAAAGGACCCCTTG-3), and GAPDH primers
5TGAAGGTCGGAGTCAACGGATTTGGT-3, 5CATGT-
GGGCCATGAGGTC CACCAC-3).
Generation of Expression Constructs and
Retroviral Infection
Standard molecular biology techniques were used for all
constructs. For subcloning into retroviral vectors, full-
length human DDR1 isoform b was generated by PCR
using primers containing 5 BamHI and 3BamHI sites
and DDR2 used primers with 5 XhoI 3 NotI sites. Both
constructs have a hemagglutinin (HA) epitope tag on the
3 end. The sequences of all PCR-generated constructs
were confirmed by sequencing. Primer sequences used
for cloning are available on request. All retroviral expres-
sion plasmids were constructed using the pBM-IRES-
PURO,32 expressing the puromycin resistance gene
(PAC) as a selectable second cis-tron gene, generated
from the original pBM-IRES-EGFP, generously provided
by GP Nolan (Stanford University, Stanford, CA).
Immunocytochemistry and Laser
Microdissection
Segments of the aortae of nonhuman primates fed a
hypercholesterolemic diet were fixed in methyl Carnoy’s
fixative and embedded in paraffin before sectioning. Tis-
sue from control lungs was provided by Lynn Schnapp,
David Thorning, Charles Frevert (University of Washington,
Seattle, WA), and Marilyn Glassberg (University of Miami,
Miami, FL). Specimens from LAM lungs were supplied by
Joel Moss (National Institutes of Health, Bethesda, MD) and
the LAM Registry. Hematoxylin and eosin staining was per-
formed to evaluate the preservation of frozen and fixed
tissues before further analyses. Fixed tissues (methyl Car-
noy’s and paraformaldehyde fixatives) were used for immu-
nocytochemical analysis. Serial sections were blocked in
PBS and 0.1% Triton X-100 and PBS containing 3% H2O2
and 0.1% azide to eliminate endogenous peroxidase activ-
ity and with avidin/biotin blocking kit (Vector), with 5% nor-
mal sera (same species as secondary antibody). Primary
antibody incubations were 4 hours followed by horseradish
peroxidase-conjugated secondary biotinylated antibodies
(Jackson ImmunoResearch Laboratories, Inc.) for 1 hour,
and then developed with avidin-peroxidase (Vectastain
ABC kit elite, Vector), all at room temperature. Antibody
binding was visualized with diaminobenzidine and sections
were counterstained with methyl green.
For microdissection 10-m-thick frozen sections from
normal and LAM tissue were placed on glass slides con-
taining a 1.35-m thick PEN membrane (Stem Cell Tech-
nology), acetone-fixed for 10 minutes at 4°C, blocked with
5% normal goat serum, and incubated with anti--actin
antibody (1 g/ml) overnight at 4°C. After washing, the
slides were incubated with biotinylated anti-mouse IgG
(Vector), then horseradish peroxidase-conjugated strepta-
vidin (Jackson ImmunoResearch Laboratories, Inc.), and
visualized with diaminobenzidine. Slides were kept at
20°C until use. Only -actin-positive cells were collected
using the PALM Laser Microbeam Microdissection plus La-
ser Pressure Catapulting system (P.A.L.M. Mikrolaser
Tachnologie, Munich, Germany) that allows the precise out-
line and collection of positive cells without the inclusion of
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unstained cells in the same area. To collect a similar num-
ber of cells from each specimen, images of -actin-stained
slides were captured using Spot Insight digital camera (Di-
agnostic Instruments, Sterling Heights, MI) and area occu-
pied by SMCs was quantified using color threshold with
Image Pro Plus (Media Cybernetics, Silver Spring, MD)
software. Comparable total areas were then microdis-
sected, and collected cells were lysed as described under
protein analysis and immunoprecipitation.
Collagen Degradation Assay
For the collagen degradation assay, SMCs were cultured
on fluorescein isothiocyanate (FITC)-conjugated poly-
merized collagen gels (1.0 mg/ml final concentration;
Elastin Products Co.), and at subsequent time points
conditioned media were collected and FITC-conjugated
collagen fragments measured using a Fusion microplate
analyzer (Packard BioScience, Inc., Meriden, CT).
Results
mRNA Levels for DDR1 and DDR2 Are Up-
Regulated in the Lungs of LAM Patients, but Do
Not Change Significantly between Normal and
Atherosclerotic Arteries
A major component of obstructive diseases of blood
vessels and the lung is degradation and abnormal repair
and deposition of new ECM, typified by the deposition of
fibrillar type I collagen.33,34 Regulated remodeling of the
ECM in disease processes such as atherosclerosis and
LAM, two diseases characterized by excessive accumu-
lation of large numbers of SMCs, is poorly understood but
is thought to be regulated in part by cell surface recep-
tors for specific ECM molecules. A family of collagen
receptors with protein tyrosine kinase activity, DDR1 and
DDR2, have been identified in injury-induced remodeling
of blood vessels22 and the liver.25 To begin to examine
the potential role of DDR in collagen remodeling in ath-
erosclerosis and LAM, we evaluated their expression.
Five different isoforms of human DDR1, all generated by
alternative splicing, have been previously described,19,31,35
whereas only one DDR2 transcript has been identified. We
used semiquantitative RT-PCR and primers designed from
the human sequence to compare levels of DDR1 and DDR2
in diseased and normal tissue with GAPDH to control for the
relative quality and quantity of total RNA. In normal and
diseased arteries from nonhuman primates on a high cho-
lesterol diet, we detect three DDR1 isoforms (a, b, and d;
Figure 1A). Although the overall expression of DDR1 does
not change dramatically, there is an apparent decrease in
DDR1d mRNA levels and an increase in expression of
DDR1a isoform in advanced atherosclerotic lesions (Figure
1A). In contrast, DDR2 mRNA levels are not modulated
between normal aortae and aortae with early or advanced
lesions (Figure 1A). Human and nonhuman primate lesions
at early and late stages of development are characterized
by different cellular compositions within lesions—early le-
sions contain primarily macrophage-rich foam cells and late
lesions have well-developed fibrous caps with SMCs cov-
ering the foam cells and necrotic core (Figure 2). Although
95% of the chimpanzee and human genome can be directly
aligned with an average sequence divergence of 1.2%,36,37
we cannot eliminate the possibility that DDR1 isoforms may
vary between nonhuman primates analyzed in this study
and humans. However, fragments of comparable size were
observed in nonhuman primate and human tissue (Figure 1,
A and B).
Comparison of normal lung and LAM tissue using the
same set of primers demonstrated an increase in mRNA
levels of DDR1a and DDR1b isoforms in lung affected by
LAM disease as compared to normal controls (Figure
1B). DDR1d was variably detected in LAM specimens,
and always represented a very small percentage of the
total DDR1 (Figure 1B and data not shown). In contrast to
arteries, DDR2 mRNA was increased in LAM specimens
compared with normal lung (Figure 1B). Although DDR1
and DDR2 mRNA levels are not significantly altered dur-
ing the development of lesions of atherosclerosis, levels
of both DDR1 and DDR2 mRNA seem to be up-regulated
in LAM nodules.
Multiple Cell Types Express DDR1 and DDR2 in
Lesions of Atherosclerosis and the Lungs of
LAM Patients
Immunohistochemistry was used to evaluate cell type
and relative expression of DDR1 and DDR2 in lesions of
atherosclerosis and in lungs of patients with LAM. As
shown in Figure 2, both DDR1 and DDR2 are expressed
Figure 1. DDR1 and DDR2 mRNA are differentially expressed in lesions of
atherosclerosis and LAM nodules. A: Total RNA was extracted from frozen
aortae of control nonhuman primates (n  2, normal) or from animals fed a
hypercholesterolemic diet for varying periods of time resulting in different
stages of lesion development (n 2, early and advanced). B: Normal human
lung (n  3) was compared with LAM lung (n  3). First-strand cDNA
synthesis was generated from isolated RNA and the PCR reaction was per-
formed as described in Material and Methods. Plasmid DNA containing the
human sequence for DDR1b and DDR2 was used as a positive control. PCR
products for DDR1 isoforms a, b, and d, DDR2, and GAPDH are indicated
with arrowheads.
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Figure 2. DDR1 and DDR2 are present in SMCs in lesions of atherosclerosis. Immunohistochemical analysis was performed on serial sections of aortae of
nonhuman primates fed a hypercholesterolemic diet with early (A) and advanced (B) atherosclerotic lesions. Adjacent sections were stained with antibodies
recognizing a marker for SMCs (-actin) or macrophages (HAM-56), and DDR1 (C-20, rabbit polyclonal; Santa Cruz Biotechnology) or DDR2 (N-20, goat
polyclonal; Santa Cruz Biotechnology). A: Recruited macrophages and medial SMCs express DDR1 and DDR2. B: SMCs present in the fibrous cap and
macrophages in the core of advanced atherosclerotic lesions express DDR1 and DDR2.
Figure 3. DDR1 and DDR2 are induced in SMCs in LAM nodules. Immunohistochemical analysis was performed on serial sections of specimens from LAM patients
(A) and normal controls (B). Adjacent sections were stained with antibodies recognizing a marker for SMCs (-actin) or macrophages (HAM-56), and DDR1 (C-20,
rabbit polyclonal; Santa Cruz Biotechnology) or DDR2 (N-20, goat polyclonal; Santa Cruz Biotechnology), and control isotype-matched antibodies. A: SMC-rich
nodules, characteristic of the lungs of LAM patients, express both DDR1 and DDR2, but no significant staining is seen with isotype-matched normal IgG. SMCs
in vessels (arrowheads) express lower levels of DDR1 and DDR2 than adjacent LAM nodules (arrow). B: DDR1 and DDR2 are also expressed at low levels in
interstitial and arterial SMCs present in normal lungs but are expressed at higher levels in epithelial cells, including ciliated epithelium (arrows), and alveolar
macrophages (arrowheads).
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in early and advanced lesions of atherosclerosis, as well
as in the underlying medial SMCs. In early lesions, we
detect expression of both DDR1 and DDR2 in macro-
phages that are the major component of the developing
lesions (Figure 2A). DDR1 and DDR2 are also abundant
in advanced lesions within SMCs localized in the fibrous
cap and macrophages in the necrotic core (Figure 2B).
This distribution is typical of lesions in eight different
nonhuman primates examined.
Seven segments of lung tissue from LAM patients were
evaluated, and positive staining for -smooth muscle actin
is observed in the SMCs that comprise the nodules char-
acteristic of LAM lesions (Figure 3A). In LAM nodules, many
of the SMCs express DDR1 and DDR2 (Figure 3A), and
SMCs surrounding blood vessels in LAM lungs also ex-
press both receptors, but at lower levels than LAM nodules
in the same section (Figure 3A and data not shown). DDR1
and DDR2 are also found in macrophages in and around
LAM nodules (Figure 3A and data not shown). In normal
lung, DDR1 and DDR2 staining is prominent in ciliated
epithelial cells and alveolar macrophages, with lighter stain-
ing of vascular and interstitial SMCs (Figure 3B and data not
shown). The specificity of the antibodies recognizing DDR1
and DDR2 was confirmed by the complete abrogation of
immunoreactivity by co-incubation with the peptides used
to generate the antibodies (data not shown).
DDR1 and DDR2 Are Activated by Polymerized
Collagen Gels in Human SMCs
Cultured SMCs maintain some of the characteristics of
SMCs in vivo, but some features, such as the expression
of specific integrin receptors for ECM can change dra-
matically.38 To begin, to examine the potential role of
DDR1 and DDR2 in SMC remodeling of the ECM, we
investigated their expression and regulation in normal
human arterial SMCs cultured on polymerized collagen
gels—a model used to evaluate ECM remodeling.
By RT-PCR, we detect the expression of DDR1a and
DDR1b message in cultured SMCs with variable expres-
sion of DDR1d (Figure 4A, top). To determine the relative
expression of DDR1 isoforms by Northern analysis, we
designed two different probes—the first recognizing all
five DDR1 isoforms and the second specific for isoforms
b and c that contain additional cytoplasmic sequences
not present in other DDR1 isoforms. As shown in Figure
4A, bottom, both probes detect the predicted DDR1 mes-
sage of 4.2 kb35 in SMCs cultured on polymerized
collagen gels. The probe for DDR2 detects two separate
mRNA species of 9.5 kb and 4.5 kb (Figure 4A, bottom).
Thus, both receptors are present in human SMCs cul-
tured on polymerized collagen gels and they appear to
express two of the three DDR1 isoforms observed in
tissues from atherosclerotic and LAM lesions.
Western blot analysis of detergent cell extracts using
antibodies recognizing either DDR1 or DDR2 reveal nu-
merous species including 125- and 130-kd forms, that
have been previously shown to represent mature DDR1 and
DDR2, respectively (Figure 4B). To determine the specificity
of these antibodies and subsequently study the function of
DDR1 and DDR2, we retrovirally overexpressed HA
epitope-tagged forms of DDR1 and DDR2 in SMCs. After
retroviral transduction, we observe10- to 20-fold increase
in expression levels of DDR1 and DDR2 by Western blot
analysis (data not shown). DDR2 expression levels were at
least twofold higher than those in cells overexpressing
DDR1. Antibodies to the HA epitope tag recognize a 125-
and 130-kd species of DDR1 and DDR2 (Figure 4C), similar
to the mature forms of endogenous DDR1 and DDR2 (Fig-
ure 4B). Western blot performed after depletion of cell sur-
face proteins by biotinylation of the cell surface and incu-
bation with agarose-streptavidin confirmed that these 125-
and 130-kd forms were the only DDR1 and DDR2 species
present at the cell surface (data not shown).
Additional molecular species of DDR1 (62-kd spe-
cies) and DDR2 (90-, 50-, and 45-kd species) are ob-
served with antibodies to DDR (Figure 4B) and to HA in
cell lysates from SMCs overexpressing HA epitope-
tagged DDR1 and DDR2 (Figure 4C). The 62-kd product
of DDR1 corresponds in size to a previously described
C-terminal cleavage product of the full-length DDR1 gen-
erated by shedding.39 However, the multiple DDR2 spe-
cies have not been previously characterized, and incu-
bation with inhibitors for MMP, cysteine proteases,
proteasome, lysosome, -secretase did not change the
relative expression of the lower molecular weight species
Figure 4. DDR1 and DDR2 are expressed in cultured human SMCs and
activated by polymerized collagen gels. A: RT-PCR (top) and Northern blot
analysis (bottom) were performed with total RNA isolated from human
SMCs cultured on polymerized collagen gels for 24 hours. RT-PCR for DDR1
was performed as described in Figure 1 using two different SMC isolates. For
Northern blot analysis, the membrane was hybridized with probes recogniz-
ing all DDR1 isoforms, DDR1 isoforms b and c, and DDR2. B: Expression of
DDR1 and DDR2 was evaluated by Western blot analysis of total cell lysates
prepared from SMCs cultured on polymerized collagen gels for 24 hours.
Arrowheads indicate smaller molecular species of DDR1 (62 kd) and DDR2
(90, 50, and 45 kd). C: Expression of HA epitope-tagged DDR1 and DDR2 in
retrovirally transduced human SMCs cultured on polymerized type 1 collagen
for 24 hours was evaluated by Western blot analysis with antibody recog-
nizing the HA epitope tag. D: Activation state of DDR1 and DDR2 in human
SMCs cultured on polymerized type 1 collagen for 4 hours was evaluated by
immunoprecipitation with the anti-HA epitope antibody and Western blot-
ting with anti-phosphotyrosine antibody. For all data shown in this figure,
results are representative of three independent experiments.
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of DDR2 in SMCs cultured on polymerized collagen gels
(data not shown).
Both soluble and immobilized type I collagen has been
previously shown to activate DDR1 and DDR2.19,20 To
test the activation of DDR1 and DDR2 in response to
polymerized collagen gels, we used SMCs overexpress-
ing DDR1 and DDR2. Tyrosine phosphorylation of both
DDR1 and DDR2 are detected in SMCs on polymerized
collagen gels (Figure 4D). Similar activation is observed
after 4 or 24 hours of culture (data not shown). The lower
molecular weight protein products of DDR1 (62 kd) and
DDR2 (90 kd) are also phosphorylated on tyrosine resi-
dues (Figure 4D). Taken together, our data show that
cultured human vascular SMCs express both DDR1 and
DDR2, and polymerized collagen gels specifically induce
their tyrosine phosphorylation.
Overexpression of DDR1 or DDR2 in SMCs
Leads to Down-Regulation of Collagen
Production and Increased Matrix
Metalloproteinase Activity
To characterize the role of DDR1 and DDR2 in the mod-
ulation of SMC ECM remodeling, we compared the
mRNA expression levels of Col1(I), MMP1, and MMP2—
the major MMP secreted by SMCs—after 72 hours of
culture on polymerized collagen gels. Overexpression of
DDR1 and DDR2 results in a reduction of 46.0  11.7%
and 58.8  17.3% of Col1(I) mRNA levels, respectively
(Figure 5A), whereas overexpression increases MMP1
mRNA levels by 1.87  0.23-fold and by 2.62  1.0-fold,
respectively (Figure 5B). In contrast, under the same
experimental conditions we did not observe any signifi-
cant change in the levels of MMP2 mRNA (Figure 5C). At
the protein level, evaluation of collagen synthesis by
measuring [3H]-proline incorporation into secreted colla-
gen demonstrates that overexpression of DDR2, and to a
lesser extent DDR1, leads to a reduction of collagen
production by 30.3  5.5% and 19.5  2.1%, respec-
tively (n  3). Consistent with the observed induction of
mRNA, MMP1 levels increase by 3.23  0.21-fold and
4.57  0.56-fold for DDR1 and DDR2 (n  3), respec-
tively (Figure 6A). Gelatin zymography also reveals that
DDR2, but not DDR1, enhanced the MMP2/pro-MMP2
ratio in human SMCs cultured on polymerized collagen
gels (Figure 6A).40
Evaluation of the impact of DDR expression on ECM
remodeling demonstrates that induction of DDR1 or
DDR2 is sufficient to increase the ability of SMCs to
degrade polymerized collagen in vitro (Figure 6B). Anal-
ysis of collagenolytic activity, measured as a release of
collagen fragments into the media of SMCs cultured on
FITC-conjugated polymerized collagen gels, shows a
significant increase in collagen degradation in SMCs
overexpressing DDR2 (151.6  16.1%, n  3) (Figure
6B). Although a trend toward increased degradation is
observed in SMCs overexpressing DDR1, the difference
is not statistically significant (111.9  12.4%, n  3) and
may reflect the lower level of overexpression of DDR1
relative to DDR2. The basal and stimulated degradation
of collagen is dependent on MMPs as demonstrated by
almost complete abrogation by the metalloproteinase in-
hibitor, GM-6001 (Figure 6B). Thus, overexpression of
DDR2, and to some extent DDR1, increases collageno-
lytic activity of human SMCs in vitro, through the induction
of MMP1 and/or activation of MMP2.
Figure 5. Collagen 1(I) and MMP1 mRNA are regulated in human SMCs
overexpressing DDR1 or DDR2. A to C: Northern blot analysis was per-
formed with total RNA isolated from human SMCs retrovirally transduced
with pBM-IRES-PURO retrovirus encoding control vector (PURO), DDR1, or
DDR2 and cultured on polymerized collagen gels for 72 hours. Nylon mem-
branes were hybridized with probes recognizing Col1(I), MMP1, MMP2,
and GAPDH. Expression levels of Col1(I) (A), MMP1 (B), and MMP2 (C)
mRNA were normalized to the GAPDH signal, all quantified with phospho-
imager analysis and Imagequant software (bottom). All results are repre-
sentative of three independent experiments.
Figure 6. MMP-mediated collagen degradation is increased in SMCs overex-
pressing DDR1 or DDR2. Human SMCs were transduced with pBM-IRES-
PURO retrovirus encoding control vector (PURO), DDR1, or DDR2. All of the
data are representative of three independent experiments. A: MMP1 expres-
sion was analyzed in the conditioned media by Western blot analysis, and
MMP2 expression and processing were analyzed in conditioned media by
gelatin zymography after 72 hours of culture on polymerized collagen gels.
B: Retrovirally transduced human SMCs were cultured on polymerized FITC-
conjugated collagen in the presence or absence of the MMP inhibitor
GM6001 (50 mol/L final concentration). Conditioned media were collected
after 72 hours. Release of FITC-conjugated collagen was measured with a
96-well plate reader. *, P  0.05 by Student’s t-test.
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Characterization of MMP Activity in Tissues
Derived from LAM Patients
Our studies in cultured SMCs demonstrate that DDR2, and
to some extent DDR1, play a significant role in collagen
turnover through the simultaneous increase of MMP-
dependent collagen breakdown and reduction of collagen
production. Evaluation of changes in the expression levels
of DDR1 and DDR2 in normal vessels versus diseased
arteries and normal lung compared with LAM lesions dem-
onstrate an apparent increase in expression levels only in
LAM lesions, particularly the induction of DDR2 (Figure 1).
Thus, collagen and elastin degradation mediated by MMP
in the remodeling of the tissue architecture during LAM14,16
may be related to the observed changes in DDR expres-
sion. To examine the MMPs involved in LAM, we first com-
pared the protein levels of MMP1 and the gelatinolytic ac-
tivities in protein extracts from LAM tissues with normal
control lungs (Figure 7A). We detect a significant increase
in MMP1 expression in all LAM tissues (n 7) as compared
to normal lung (n  4) (3.00  1.27-fold) (Figure 7A and
data not shown). Two prominent enzymes are observed by
zymography: MMP2 (72 kd/68 kd) and MMP9 (92 kd),
based on their molecular weights and ability to degrade
gelatin (Figure 7A). Although we observe variable MMP9
levels between samples, increased processing of pro-
MMP2 to active MMP2 is a consistent finding in all LAM
tissues as compared to normal lung tissue (Figure 7A).
To investigate the cellular source for MMP2, we used
laser microdissection technology to selectively analyze the
gelatinolytic activities of protein extracts from -smooth
muscle actin-positive cells within LAM nodules. SMCs dis-
sected from two different LAM specimens contain40% of
the total MMP2 in the active form (Figure 7B), whereas the
percentage of active MMP2 is significantly lower in total
tissue protein extracts (10 to 15% of the total) (Figure 7B). A
direct comparison of the gelatinolytic activity of protein ex-
tracts isolated from normal perivascular SMCs and LAM
SMCs reveals a shift to an increased proportion of active
MMP2 in SMCs derived from LAM tissues (Figure 7C).
Taken together, these results suggest that SMCs are the
major source of active MMP2 in LAM disease, and provide
evidence that SMCs in LAM nodules are present in a phe-
notypic state characterized by higher MMP2 activation than
normal lung vascular SMCs.
Discussion
DDR1- and DDR2-Mediated Signaling
Regulates Collagen Turnover in Human SMCs
A number of different factors can regulate the expression
of MMP1 and activation of MMP2, including MMP sub-
strates. Hence ECM components, such as polymerized
collagen gels, increase fibroblast expression of
MMP1,41–43 and activate MMP2 in SMCs.40 These stud-
ies show that cell-ECM interactions, in particular those
mediated through both 11 and 21 integrin collagen
receptors, regulate MMP1 expression and MMP2 activa-
tion.40,41 However, other collagen receptors have been
identified, and in the present study we tested the hypoth-
esis that DDR1- and DDR2-mediated signals can regu-
late collagen remodeling in SMCs. Our studies demon-
strate that signaling from both DDR1 and DDR2
negatively regulates collagen biosynthesis and induces
MMP1 expression. In addition, we observe a specific
activation of MMP2 in SMCs overexpressing DDR2, but
not DDR1.
Studies of the role of DDR in cellular function have
primarily focused on the analysis of mouse cells because
of the availability of mice with targeted deletion of DDR1
and DDR2.21,24 However, mice do not possess a homol-
ogous gene to human MMP1, and consequently very little
is known about DDR-mediated regulation of MMP1 ex-
pression. Only DDR2 has been associated with altered
MMP1 activity using the human fibrosarcoma cell line HT
1080 transduced with DDR2.19 Therefore, our study is the
first to establish a role for DDR1 and DDR2 in MMP1
expression in primary human cells. We also show that
increased levels of MMP1 and activation of MMP2 corre-
late well with the ability of cultured SMCs to degrade
fibrillar collagen.
Our in vitro study linking DDR with collagen remodeling
is supported by the in vivo finding that ECM deposition is
substantially increased in the mammary gland in DDR1-
null mice.21 In addition, a defect in blastocyst implanta-
Figure 7. SMCs present in LAM lesions have higher levels of MMP1 and
activated MMP2 than those from normal lung. A: Total protein extracts were
prepared from five 20-m-thick frozen sections of normal (C101, C109, C111)
and LAM (L102, L103, L105, L111) lungs. Protein concentrations were deter-
mined and MMP1 expression was analyzed by Western blot and gelatinase
activity by gelatin zymography. B: -Actin-positive cells were dissected with
a laser-dissecting microscope (MD) from 10-m-thick frozen sections from
two different LAM patients for comparison by zymography with total protein
extracts of the same specimens. C: -Actin-positive cells were dissected from
vessels present in normal lung (C109, C111) and from LAM nodules (L102,
L106, L111, L115) for analysis by gelatin zymography.
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tion in DDR1-null mice has been ascribed to a reduction
of MMP activity.21 In contrast, the expression pattern of
MMP2, MMP9, MMP13, and MT1-MMP are normal in
DDR2-null mice,24 although it is possible that DDR1 func-
tions compensate for the loss of DDR2 in these mice.
Interestingly, the absence of the major collagen integrin
receptor expressed in SMCs in vivo, such as 11 inte-
grin, causes loss of feedback regulation of collagen syn-
thesis, revealing a common, receptor-mediated regula-
tory mechanism of collagen deposition.44 However, in
1-null mice a simultaneous increase in collagenase 3
(MMP13) overcomes the loss of negative feedback by
increasing collagen breakdown, whereas DDR1-null
mice and DDR2-null fibroblasts, have decreased MMP2
expression.22,26,41
The role of DDR2 in MMP2 expression has been pre-
viously shown in mouse fibroblast and hepatic stellate
cells.25,26 In particular, analysis of 293T cells transiently
transfected with DDR2 and the comparison between
DDR2-null and heterozygous skin fibroblasts, show that
DDR2 signaling induces MMP2 promoter activity.26 In
contrast, in the present study, human SMCs overexpress-
ing DDR2 do not show any difference in MMP2 mRNA
expression, but a significant increase in MMP2 levels and
activity, suggesting a different level of regulation between
cell types. It is important to note that our observation is
consistent with several examples showing that MMP2
expression levels are usually regulated at the transla-
tional level.1
Potential Role of DDR1 and DDR2 in Collagen
Remodeling Observed in Atherosclerosis and
LAM Disease
At late stages of atherosclerosis, stability of the fibrous
cap can be compromised by enzyme-mediated degra-
dation of type I collagen and elastin that provide most of
the cap’s biomechanical strength. Focal degradation of
the fibrous cap often leads to its rupture that is followed
by thrombosis and can result in complete vessel occlu-
sion associated with heart attacks and strokes. In cul-
tured human SMCs, we have established a role for DDR
in reduced collagen biosynthesis and increased MMP-
dependent collagen degradation. Moreover, an elastino-
lytic activity assay performed using human SMCs, has
shown that DDR2 overexpression leads to 3.58 1.4-fold
increase in elastin degradation, which was completely
blocked by the MMP inhibitor GM-6001 (data not shown).
These data strongly suggest a potential role for DDR
activation in influencing plaque stability. Consistent with
this possibility, it has been shown that expression of
DDR1 is increased after acute balloon injury of a normal
rat carotid artery and DDR1-null mice develop smaller
neointima 14 days after balloon injury.22 In vitro, DDR1-
null SMCs appear to have a decreased proliferative and
migratory response and reduced MMP2 and MMP9 ex-
pression.22
However, the role of DDR-mediated signaling in colla-
gen remodeling during atherosclerosis is still uncertain,
although our analyses of atherosclerotic lesion develop-
ment demonstrate that both DDR1 and DDR2 are ex-
pressed in SMCs localized to the fibrous cap and mac-
rophages in early lesions and within the necrotic core.
Nevertheless, we failed to observe a significant modula-
tion of DDR1 or DDR2 mRNA or protein expression levels
at different stages of atherosclerosis as compared with
normal vessels from nonhuman primates. Until the com-
plete sequence of the nonhuman primate is available, our
studies cannot exclude the possibility of differences be-
tween nonhuman primate and human DDR isoforms.
However, our data demonstrate comparable fragments
from human and nonhuman primate tissue consistent
with their extremely low sequence divergence.36,37
Very little is known about the regulation of DDR signal-
ing in vivo. At least three different mechanisms have been
proposed to regulate DDR signaling: alternative splic-
ing,35 ectodomain shedding,39 and the extracellular con-
centration of collagen.25 The latter mechanism is sup-
ported by evidence that collagen content, which
increases after liver injury, probably constitutes the limit-
ing factor for DDR2 activation.25 In fact, DDR2 phosphor-
ylation is detected only after injury in which collagen
deposition is increased, despite its expression in both
normal and diseased liver.25 Moreover, our in vitro data
on DDR-mediated reduction of collagen deposition and
MMP-dependent collagen breakdown may be indicative
of a negative feedback loop whereby DDR signaling
reduces the ligand availability turning off DDR tyrosine
phosphorylation.
Our data in LAM specimens demonstrating apparent
sustained up-regulation of DDR1 and DDR2 implicate the
DDR in ECM remodeling in LAM disease. Although SMC
accumulation and matrix remodeling are features shared
in common by atherosclerosis and LAM, the pathogene-
sis of LAM is not understood and animal models are not
available to analyze cellular and molecular changes at
early time points. The differences observed in DDR levels
between normal and LAM lungs may be dependent on
either specific up-regulation or changes in cellular com-
position in LAM specimens. Very little is known about
MMP expression in LAM. Immunohistochemical studies
conducted on LAM biopsy specimens have provided
evidence for the presence of MMP2 in areas of ECM
remodeling.14,16 We demonstrate by Western blot analy-
sis that MMP1 is consistently up-regulated in LAM lung
specimens as compared with control lung, and provide
evidence for the presence of active MMP2 in LAM tissue.
Using laser microdissection technology, we establish that
the major source for MMP2 in LAM nodules is SMCs, and
that these cells express higher levels of active MMP2
than SMCs isolated from normal lung arteries. Although
several factors may contribute to MMP expression during
LAM, increased DDR1 and DDR2 expression levels in
SMCs contained in LAM nodules are indicative of their
involvement in ECM remodeling in LAM disease.
In conclusion, we show that DDR1 and DDR2 are
expressed in SMCs in lesions of atherosclerosis and
LAM. Phosphorylation of DDR1 and DDR2 in cultured
human SMCs in response to collagen leads to decreased
collagen biosynthesis and increased collagen and elastin
breakdown mediated by MMP1 and MMP2 that may con-
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tribute to the ECM remodeling observed during these
pathological conditions.
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